Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 474-477, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.474-477.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Use of an Enzyme Immunoassay Does Not Eliminate the Need To
Analyze Multiple Stool Specimens for Sensitive Detection of
Giardia lamblia
Kevan L.
Hanson1 and
Charles P.
Cartwright1,2,*
Department of Laboratory Medicine and
Pathology, Hennepin County Medical Center, Minneapolis, Minnesota
55415,1 and Department of Laboratory
Medicine and Pathology, University of Minnesota Medical School,
Minneapolis, Minnesota 554552
Received 29 August 2000/Returned for modification 16 October
2000/Accepted 5 November 2000
 |
ABSTRACT |
The relative sensitivities of a commercially available enzyme
immunoassay (EIA) (ProSpecT Giardia; Alexon-Trend Inc.,
Ramsey, Minn.) and conventional ovum-and-parasite (O&P) examination for the detection of Giardia lamblia in preserved stool
specimens were determined. Paired stool samples collected independently within a 7-day period from 103 patients were analyzed by both methods.
A total of 54 specimens from 30 patients (18 asymptomatically infected
with G. lamblia and 12 with symptoms consistent with intestinal giardiasis) were determined to be positive for G. lamblia, of which 48 (88.9%) were positive by microscopy and 52 (96.3%) were positive by EIA. Both specimens submitted were positive
for G. lamblia by O&P examination for 66.7% (20 of 30) of
the positive patients; for 26.7% (8 of 30) a single specimen was
positive by O&P examination, and for 6.7% (2 of 30) of those
determined to be infected with G. lamblia, both samples
were negative by microscopy. The sensitivity of conventional O&P
examination was somewhat higher in symptomatically infected
individuals, with 75% (9 of 12) of patients in this category having
G. lamblia detected in both samples, compared with 61% (11 of 18) of asymptomatic patients. A total of 24 positive patients (80%)
had G. lamblia antigen detected by EIA in both submitted
samples, 4 positive patients (13.3%) had one specimen positive by EIA,
and the EIA was negative in both specimens from 2 infected individuals
(6.5%), the sensitivity of EIA was substantially equivalent in
asymptomatic and symptomatic individuals (77 versus 83% of patients
with positive results on both specimens). Although the sensitivity of
EIA for the detection of G. lamblia on a single stool
specimen was somewhat higher than that of conventional O&P examination
in symptomatic patients (83 versus 75%), in asymptomatic patients (77 versus 61%), and overall (80 versus 67%), examination of two
specimens by either EIA or microscopy was necessary to achieve a
diagnostic sensitivity of greater than 90%.
 |
INTRODUCTION |
Giardiasis is by far the most common
enteric parasitic infection in the United States, with an estimated 500 thousand to 1 million cases occurring annually (5). Until
relatively recently, definitive diagnosis of this infection was
dependent upon microscopic examination of stool specimens for the
characteristic cyst and trophozoite forms of Giardia
lamblia. Unfortunately, the sensitivity of conventional
ovum-and-parasite (O&P) examination on a single stool specimen for
G. lamblia has been shown in several studies to be less than
optimal (1, 4, 9, 11) and in a recent study conducted in
our laboratory was determined to be only 74% (3). The
poor sensitivity of a single O&P examination for diagnosing giardiasis
is primarily due to intermittent or low-level shedding of parasites by
infected individuals (4) and is one of the principal
reasons that parasitology textbooks and laboratory manuals recommend
that multiple, independently collected stool specimens be obtained for
O&P examination (6, 7).
The commercial availability of enzyme immunosorbent assays (EIAs) for
detecting Giardia-specific antigens in stool specimens has
provided a potentially attractive alternative to conventional O&P
examination for diagnosing giardiasis. A number of clinical evaluations of Giardia EIAs have found them to be rapid and,
perhaps more importantly, cost-effective tools for diagnosing infection with G. lamblia (1, 2, 8, 9, 11, 12, 14). The sensitivity of EIA in these studies has been at worst comparable (8, 14) and in most cases somewhat superior (1, 2, 9, 11, 12) to O&P examination. Indeed, for those laboratories that serve patient populations in whom the prevalence of pathogenic enteric parasites other than G. lamblia approaches zero,
routine use of Giardia EIA rather than O&P examination has
been suggested (2).
G. lamblia is the most commonly identified pathogenic
enteric parasite in specimens submitted to the Hennepin County Medical Center (HCMC) laboratory for O&P examination, with an annual
per-specimen prevalence rate of approximately 10% (3).
This high prevalence of G. lamblia infection is in part
attributable to the institution's role in mandated health screening of
newly domiciled refugees, many of whom are asymptomatically infected
with intestinal parasites. The issue of how to most cost-effectively
utilize Giardia EIA testing in a high-prevalence setting
was, therefore, the primary motivator for this study, since most of the
studies published to date comparing Giardia EIA with O&P
examination have not assessed whether EIA testing of a single specimen
results in a diagnostic yield comparable to that obtained if multiple
stool samples are examined microscopically. We sought to answer this
question by prospectively comparing the sensitivity of a commercial
Giardia EIA with routine O&P examination in the
high-prevalence population served by HCMC.
 |
MATERIALS AND METHODS |
Between February and June 1999, 206 stool samples collected from
103 patients attending HCMC or its outlying clinics were evaluated for
the presence of G. lamblia by both conventional O&P
examination and the ProSpecT Giardia Microplate assay
(Alexon-Trend Inc., Ramsey, Minn.). To be included in the evaluation,
patients had to have two stool samples submitted to the laboratory for O&P examination that had been independently collected within a 7-day
time period. All specimens were received in the ParaPak ULTRA Stool
System (Meridian Diagnostics, Cincinnati, Ohio), consisting of stool
preserved in 10% formalin in one vial and stool fixed in polyvinyl
alcohol in the other. Formalin-preserved material was concentrated
prior to examination by use of a formalin-ethyl acetate sedimentation
technique as recommended by the manufacturer of the specimen collection
kit. Concentrates were read as wet mounts by examining the entire area
under a 22- by 50-mm coverslip, using a 10× objective for screening
and 40× objective for parasite identification. Permanently stained
preparations of stool specimens were made with the material preserved
in polyvinyl alcohol by use of Wheatley's (13) modified
trichrome stain (Meridian Diagnostics). Trichrome-stained smears were
read by examining at least 300 fields using a 100× oil immersion objective.
Giardia EIA testing was performed on unconcentrated
formalin-preserved specimens using the manufacturer's recommended
procedure. The EIA testing was performed in a blinded manner; specimens
were assigned unique identifiers and unlinked from conventional O&P results. Upon completion of assay procedures, absorbance values were
measured using a spectrophometer and interpreted using criteria provided by the manufacturer.
In the absence of a true "gold standard" for determining the
diagnostic sensitivities of the two test procedures, specimens meeting
the following criteria were considered to be positive for G. lamblia: (i) positive by O&P examination and positive or negative
by Giardia EIA and (ii) negative by O&P examination and positive by Giardia EIA if the specimen was positive by
Giardia EIA upon repeat and (a) the other specimen in the
pair was positive by O&P examination or (b) the other specimen in the
pair was negative by O&P examination but repeatedly positive by
Giardia EIA or (c) the other specimen in the pair was
negative by Giardia EIA but the patient was clinically
symptomatic and was treated for giardiasis.
 |
RESULTS |
Of the 206 stool samples tested, 54 specimens (26.2%) collected
from 30 patients (29.1%) were determined to be positive for
G. lamblia.
Conventional O&P examination detected 88.9% (48 of 54) of the positive specimens, while the Giardia EIA
exhibited a sensitivity of 96.3% (52 of 54). Two O&P-negative
specimens that were positive on initial testing with the
Giardia EIA were negative upon repeat testing, and since the
other sample in each pair was negative by both Giardia EIA
and conventional O&P examination and neither patient was symptomatic,
these were considered false-positive results. The specificity of the
Giardia EIA was, therefore, determined to be 98.7% (150 of 152).
Of the 103 patients evaluated in the study, only 41 (39.8%) had
clinical symptoms of giardiasis at the time of specimen collection. The
remaining 62 individuals (60.2%) were asymptomatic but had recently
entered the United States as refugees and were being evaluated for
enteric parasite infection as part of routine health screening. Of
those patients determined to be infected with G. lamblia,
40% (12 of 30) were symptomatic and 60% (18 of 30) were asymptomatic.
The number of specimens positive for G. lamblia by O&P
examination and Giardia EIA on a per-patient basis is shown in Table 1. The O&P examination of two
stool samples rather than one increased the diagnostic sensitivity of
this procedure by 26.6% (93.3 versus 66.7%) and improved its negative
predictive value by 9.3% (97.3 versus 88%). Testing of two stool
samples by Giardia EIA resulted in a more modest 13.3%
(93.3 versus 80%) increase in diagnostic sensitivity and 4.9% (97.3 versus 92.4%) improvement in negative predictive value compared with
analysis of a single specimen. The difference in sensitivity between
O&P examination and Giardia EIA was somewhat more prominent
in asymptomatically infected individuals. Of the 18 individuals
asymptomatically infected with G. lamblia, 11 (61.1%) had
the parasite detected by O&P examination in both specimens examined,
whereas both specimens were positive in the Giardia EIA for
14 asymptomatic patients (77.8%) (Table 1). In contrast, both methods
detected G. lamblia in each member of a sample pair with
near-identical frequency in symptomatic individuals, on 75% (9 of 12)
and 83.3% (10 of 12) of occasions for O&P examination and
Giardia EIA, respectively (Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Detection of G. lamblia in paired,
independently collected, preserved stool samples using either
conventional microscopic O&P examination or ProSpecT
Giardia EIA
|
|
Two patients had positive O&P examinations but were negative by
Giardia EIA testing. In both instances the patients were
asymptomatic, only a single specimen was positive, and rare cyst forms
of G. lamblia were observed only in fecal concentrates; all
of these are findings suggestive of a low parasite burden. Two
additional patients were diagnosed as positive for G. lamblia by Giardia EIA but were negative by
conventional O&P examination. One of these patients was
asymptomatic and consequently was not treated; however, both stool
samples collected from this individual were repeatedly positive by
Giardia EIA, and thus this was considered a true positive.
The second patient had a single stool specimen repeatedly positive by
Giardia EIA, was symptomatic, had a sibling diagnosed
concurrently with giardiasis, and was treated with metronidazole with
resolution of symptoms.
 |
DISCUSSION |
A number of evaluations of the ProSpecT Giardia EIA
have been published in the peer-reviewed literature (1, 2, 8, 9,
11), with reported sensitivities varying from 91%
(1) to 100% (2) and specificities
of 98% (1) to 100% (2). In most of these
studies, Giardia EIA was compared on a direct per-specimen
basis with microscopic examination of stool specimens, by conventional
O&P examination either alone (1, 2, 11) or in combination
with direct fluorescent antibody staining (8). In our
evaluation, Giardia EIA detected 52 of 54 specimens
determined to be positive for G. lamblia using O&P
examination plus clinical criteria as the gold standard, for a
diagnostic sensitivity of 96.3% (conventional O&P examination had a
sensitivity of 88.9%). Two specimens were deemed to have given
false-positive Giardia EIA results, and thus the specificity
of the test in our hands was 98.7%. Our data substantially confirm,
therefore, those of previous studies in demonstrating that the ProSpecT
Giardia EIA is a sensitive and specific alternative to
conventional O&P examination for diagnosing giardiasis.
By examining paired, independently collected stool samples, we
determined the diagnostic sensitivity of a single O&P examination to be
66.7% (20 of 30 cases detected). This is similar to the sensitivity of
74% reported for a previous study conducted in our laboratory
(3) and comparable to sensitivities reported by other
investigators (1, 11, 12). This relative lack of
sensitivity of O&P examination, which presumably is reflective of low
parasite numbers or intermittent shedding of organisms, means that at
least two independently collected stool specimens need to be submitted
for O&P examination to obtain a diagnostic sensitivity of greater than
90%. A sensitivity of 93.3% was achieved in the present study by
microscopically examining two stool samples for parasites. Given that
the sensitivity of the Giardia EIA, at least on a
per-specimen basis, is higher than that of O&P examination, it seemed
conceivable that the sensitivity of a single Giardia EIA
might approach the sensitivity of paired-stool-sample O&P examination.
In the present study, however, the sensitivity of Giardia
EIA on a single sample was 80% (24 of 30 cases detected), which is a
considerable improvement over conventional O&P examination of a
single specimen (14%; four additional cases), but not
equivalent in sensitivity to O&P examination of two stool specimens.
The improvement in sensitivity effected by using Giardia EIA
rather than conventional O&P examination on a single specimen was
somewhat greater in asymptomatically infected individuals
undergoing routine health screening (17%; three additional cases) than
in individuals with symptoms of intestinal giardiasis (8%; one
additional case); however, in neither population was a single EIA
comparable in sensitivity to O&P examination of paired specimens.
Only one of the previously published evaluations of Giardia
EIAs used analysis of paired, independently collected stool samples to
evaluate the comparative sensitivity of conventional O&P examination and EIA (9). Mank et al. (9) determined the
sensitivity of a single O&P examination to be 80%, with
microscopic examination of two stool samples increasing the
diagnostic yield to 96.4%. Use of a Giardia EIA improved
the sensitivity of a single-stool-sample analysis to 92.7%, with a
negative predictive value substantially equivalent to that
achieved by microscopically examining two specimens (98.7 versus
99.4%). Based on these findings, those authors concluded that a single
Giardia EIA could replace multiple O&P examinations for
patients at minimal risk for infection with parasites other than
G. lamblia. Interestingly, the 12.7% increased sensitivity (92.7 versus 80%) of single-sample Giardia EIA testing over
single-sample microscopic examination reported by Mank and colleagues
(9) was essentially matched by the 13.3% increase (80 versus 66.7%) observed in our study. The primary difference in
findings between the two studies was in the sensitivity of a single O&P
examination. In our study, in only 66.7% of documented cases were both
stool samples positive for G. lamblia by O&P examination,
whereas in the study by Mank et al. (9), G. lamblia was detected microscopically in both samples on 80% of
occasions. A possible explanation for this considerable difference in
sensitivity of G. lamblia detection by O&P examination is
that while all the specimens examined in the previously published study
were obtained from patients with symptoms of intestinal giardiasis, in
the present study only 40% (41 of 103) of patients from whom specimens
were obtained were symptomatic. Indeed, in our study, the sensitivity
of a single O&P examination for patients exhibiting symptoms of
giardiasis was 75%, compared with only 61% in individuals
asymptomatically infected with G. lamblia (Table 1).
Nevertheless, unlike in the previous study (9), even in
symptomatically infected patients the sensitivity of a single
Giardia EIA was not comparable to that of O&P examination of
two stool samples (83.3 versus 100%).
In conclusion, the results of our study confirm previous findings,
demonstrating the superior sensitivity of Giardia EIA
testing to conventional O&P examination in both symptomatic and
asymptomatic individuals. The improvement in sensitivity achieved by
detecting G. lamblia antigen was, however, insufficient to
achieve parity between single-specimen testing with Giardia
EIA and multiple-specimen evaluation by conventional O&P examination.
In settings where the prevalence of enteric parasitic infection is low
and where the primary pathogen identified is G. lamblia,
routine testing of a single stool specimen by conventional O&P
examination has been recommended (10). Based on our
findings and on those of Mank and colleagues (9),
utilization of Giardia EIA as the routine means of enteric
parasite detection appears to be a preferable approach in such
environments, since it would improve diagnostic yield, shorten
turnaround time, and decrease labor cost. In higher-prevalence settings, however, or for patients who are at increased risk for giardiasis, the negative predictive value of the ProSpecT
Giardia EIA on a single stool sample is not sufficiently
high to exclude the possibility of G. lamblia infection. To
evaluate patients for whom the level of clinical suspicion for G. lamblia infection is moderate or high and infection with other
intestinal parasites is low, therefore, we recommend that two stool
samples be submitted to the laboratory for Giardia EIA
testing, with analysis of the second sample being performed if the
first assay yields a negative result.
 |
ACKNOWLEDGMENT |
This study was supported by Alexon-Trend Inc.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Clinical
Laboratories, MC #812, Hennepin County Medical Center, 701 Park Ave.,
Minneapolis, MN 55415. Phone: (612) 347-3026. Fax: (612) 904-4229. E-mail: charles.cartwright{at}co.hennepin.mn.us.
 |
REFERENCES |
| 1.
|
Aldeen, W. E.,
D. Hale,
A. J. Robison, and K. Carroll.
1995.
Evaluation of a commercially available ELISA assay for detection of Giardia lamblia in fecal specimens.
Diagn. Microbiol. Infect. Dis.
21:77-79[CrossRef][Medline].
|
| 2.
|
Aldeen, W. E.,
K. Carroll,
A. Robison,
M. Morrison, and D. Hale.
1998.
Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens.
J. Clin. Microbiol.
36:1338-1340[Abstract/Free Full Text].
|
| 3.
|
Cartwright, C. P.
1999.
Utility of multiple-stool-specimen ova and parasite examinations in a high-prevalence setting.
J. Clin. Microbiol.
37:2408-2411[Abstract/Free Full Text].
|
| 4.
|
Danciger, M., and M. Lopez.
1975.
Numbers of Giardia in the feces of infected children.
Am. J. Trop. Med. Hyg.
24:237-242.
|
| 5.
|
Furness, B. W.,
M. J. Beach, and J. M. Roberts.
2000.
Giardiasis surveillance, United States, 1992-1997.
Morb. Mortal. Wkly. Rep.
49:1-13[Medline].
|
| 6.
|
Garcia, L. S.
1992.
Parasitology, p. 7.0.1-7.10.7.2.
In
H. D. Isenberg (ed.), Clinical microbiology procedures handbook. American Society for Microbiology, Washington, D.C.
|
| 7.
|
Garcia, L. S., and D. A. Bruckner.
1997.
Diagnostic medical parasitology, 3rd ed.
American Society for Microbiology, Washington, D.C.
|
| 8.
|
Garcia, L. S., and R. Y. Shimizu.
1997.
Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens.
J. Clin. Microbiol.
35:1526-1529[Abstract].
|
| 9.
|
Mank, T. G.,
J. O. M. Zaat,
A. M. Deelder,
J. T. M. van Eijk, and A. M. Polderman.
1997.
Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis.
Eur. J. Clin. Microbiol. Infect. Dis.
16:615-619[CrossRef][Medline].
|
| 10.
|
Morris, A. J.,
M. L. Wilson, and L. B. Reller.
1992.
Application of rejection criteria for stool ovum and parasite examinations.
J. Clin. Microbiol.
30:3213-3216[Abstract/Free Full Text].
|
| 11.
|
Rosoff, J. D.,
C. A. Sanders,
S. S. Sonnad,
R. R. DeLay,
W. K. Hadley,
F. F. Vincenzi,
D. M. Yajko, and P. D. O'Hanley.
1989.
Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65.
J. Clin. Microbiol.
27:1997-2002[Abstract/Free Full Text].
|
| 12.
|
Scheffler, E. H., and L. L. van Etta.
1994.
Evaluation of a rapid commercial enzyme immunoassay for detection of Giardia lamblia in formalin-preserved stool specimens.
J. Clin. Microbiol.
32:1807-1808[Abstract/Free Full Text].
|
| 13.
|
Wheatley, W.
1951.
A rapid staining procedure for intestinal amoebae and flagellates.
Am. J. Clin. Pathol.
21:990-991[Medline].
|
| 14.
|
Zimmerman, S. K., and C. A. Needham.
1995.
Comparison of conventional stool concentration and preserved-smear methods with Merifluor Cryptosporidium/Giardia direct immunofluorescence assay and ProSpecT Giardia EZ microplate assay for detection of Giardia lamblia.
J. Clin. Microbiol.
33:1942-1943[Abstract].
|
Journal of Clinical Microbiology, February 2001, p. 474-477, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.474-477.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Garcia, L. S., Garcia, J. P.
(2006). Detection of Giardia lamblia Antigens in Human Fecal Specimens by a Solid-Phase Qualitative Immunochromatographic Assay. J. Clin. Microbiol.
44: 4587-4588
[Abstract]
[Full Text]
-
Johnston, S. P., Ballard, M. M., Beach, M. J., Causer, L., Wilkins, P. P.
(2003). Evaluation of Three Commercial Assays for Detection of Giardia and Cryptosporidium Organisms in Fecal Specimens. J. Clin. Microbiol.
41: 623-626
[Abstract]
[Full Text]